Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

Related Articles by Review for PubMed (Select 19673089)

1.

Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.

Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J.

World J Biol Psychiatry. 2009;10(1):70-3. doi: 10.1080/15622970701287369.

PMID:
19673089
2.

[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].

Khaldi S, Kornreich C, Choubani Z, Gourevitch R.

Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Review. French.

PMID:
19081460
3.
4.

Residual catatonic state following neuroleptic malignant syndrome.

Caroff SN, Mann SC, Keck PE Jr, Francis A.

J Clin Psychopharmacol. 2000 Apr;20(2):257-9. Review.

PMID:
10770467
5.

[Are catatonia and neuroleptic malignant syndrome related conditions?].

Vesperini S, Papetti F, Pringuey D.

Encephale. 2010 Apr;36(2):105-10. doi: 10.1016/j.encep.2009.03.009. Epub 2009 Aug 28. Review. French.

PMID:
20434626
6.

Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.

Sachdev P, Kruk J, Kneebone M, Kissane D.

J Clin Psychopharmacol. 1995 Oct;15(5):365-71. Review.

PMID:
8830069
7.

Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature.

Karagianis JL, Phillips LC, Hogan KP, LeDrew KK.

Ann Pharmacother. 1999 May;33(5):623-30. Review.

PMID:
10369628
8.

[Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].

Asztalos Z, Egervári L, Andrássy G, Faludi G, Frecska E.

Neuropsychopharmacol Hung. 2014 Mar;16(1):19-28. Review. Hungarian.

9.

Risperidone-induced neuroleptic malignant syndrome: a case report and review.

Meterissian GB.

Can J Psychiatry. 1996 Feb;41(1):52-4. Review.

PMID:
8919425
10.

Catatonia and its treatment.

Rosebush PI, Mazurek MF.

Schizophr Bull. 2010 Mar;36(2):239-42. doi: 10.1093/schbul/sbp141. Epub 2009 Dec 7. Review.

11.

[Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].

Heils A, Lesch KP.

Fortschr Neurol Psychiatr. 1997 Jan;65(1):8-15. Review. German.

PMID:
9132369
12.

Neuroleptic malignant syndrome induced by atypical antipsychotics.

Farver DK.

Expert Opin Drug Saf. 2003 Jan;2(1):21-35. Review.

PMID:
12904122
13.

[Life threatening neuroleptic malignant syndrome due to olanzapine].

Kopf A, Köster J, Schulz A, Krömker H, Becker T.

Psychiatr Prax. 2003 Jul;30(5):279-82. Review. German.

PMID:
12872187
15.

Anticholinergic toxicity masquerading as neuroleptic malignant syndrome: a case report and review.

Catterson ML, Martin RL.

Ann Clin Psychiatry. 1994 Dec;6(4):267-9. Review.

PMID:
7647837
16.

Neuroleptic malignant syndrome associated with clozapine monotherapy.

Thornberg SA, Ereshefsky L.

Pharmacotherapy. 1993 Sep-Oct;13(5):510-4. Review.

PMID:
8247922
17.

Drug-induced catatonia.

Duggal HS, Singh I.

Drugs Today (Barc). 2005 Sep;41(9):599-607. Review.

PMID:
16341291
18.

The use of atypical antipsychotics in the treatment of catatonia.

Van Den Eede F, Van Hecke J, Van Dalfsen A, Van den Bossche B, Cosyns P, Sabbe BG.

Eur Psychiatry. 2005 Aug;20(5-6):422-9. Review.

PMID:
15964746
19.

[Neuroleptic malignant syndrome. Case reports].

Berardi D, Troia M, Veronesi L, Ferrari G.

Minerva Psichiatr. 1994 Dec;35(4):199-219. Review. Italian.

PMID:
7861943
20.

Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome.

Woodbury MM, Woodbury MA.

J Am Acad Child Adolesc Psychiatry. 1992 Nov;31(6):1161-4. Review.

PMID:
1429421
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk